Davern Capital Partners, LP Diversified Active

Location: Ny

CIK: 0002003147 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 14, 2026

Total Value: $365M (100.0% shares, 0.0% debt)

Holdings (17)

PFE PFIZER INC 12.3%
Value $44.76M Shares 1,593,942 Est. Cost $25.03 Unrealized +4.6%
REGN REGENERON PHARMACEUTICALS 9.5%
Value $34.61M Shares 44,800 Est. Cost $678.68 Unrealized +13.3%
INSM INSMED INC 8.2%
Value $29.85M Shares 182,562 Est. Cost $159.03 Unrealized 0.0%
IONS IONIS PHARMACEUTICALS INC 8.0%
Value $29.05M Shares 386,903 Est. Cost $77.79 Unrealized +5.2%
NTRA NATERA INC 7.9%
Value $28.79M Shares 143,966 Est. Cost $216.43 Unrealized +4.4%
BNTX BIONTECH SE 7.4%
Value $27.11M Shares 305,055 Est. Cost $95.20 Unrealized
ARGX ARGENX SE 7.0%
Value $25.59M Shares 35,045 Est. Cost $840.95 Unrealized
LLY ELI LILLY & CO 6.9%
Value $25.09M Shares 27,279 Est. Cost $1019.21 Unrealized +2.7%
RPRX ROYALTY PHARMA PLC 6.8%
Value $24.94M Shares 520,009 Est. Cost $38.13 Unrealized +10.9%
ROIV ROIVANT SCIENCES LTD 6.6%
Value $24.19M Shares 873,398 Est. Cost $19.73 Unrealized +22.5%
LEGN LEGEND BIOTECH CORP 6.5%
Value $23.78M Shares 1,314,748 Est. Cost $21.02 Unrealized
MLYS MINERALYS THERAPEUTICS INC 3.3%
Value $12.11M Shares 447,153 Est. Cost $35.48 Unrealized -11.6%
ABVX ABIVAX SA 2.4%
Value $8.699M Shares 78,125 Est. Cost $125.94 Unrealized
GENB GENERATE BIOMEDICINES INC 2.0%
Value $7.397M Shares 591,800 Est. Cost $12.50 Unrealized
PRCT PROCEPT BIOROBOTICS CORP 1.8%
Value $6.533M Shares 261,200 Est. Cost $29.57 Unrealized 0.0%
GPCR STRUCTURE THERAPEUTICS INC 1.7%
Value $6.095M Shares 126,461 Est. Cost $48.20 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 1.6%
Value $5.916M Shares 302,457 Est. Cost $27.89 Unrealized +10.6%